Anúncio
Anúncio

TIL

TIL logo

Instil Bio, Inc. Common Stock

7.20
USD
Patrocinado
-0.19
-2.58%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

7.21

+0.01
+0.08%

Relatórios de Lucros TIL

Rácio de surpresa positiva

TIL separação 7 de 19 últimas estimativas.

37%

Próximo Relatório

Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.56
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+28.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+40.66%

Instil Bio, Inc. Common Stock earnings per share and revenue

On 13 de nov. de 2025, TIL reported earnings of -2.00 USD per share (EPS) for Q3 25, beating the estimate of -2.37 USD, resulting in a 15.50% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -2.56 USD, with revenue projected to reach -- USD, implying an aumentar of 28.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Instil Bio, Inc. Common Stock reported EPS of -$2.00, beating estimates by 15.5%, and revenue of $0.00, 0% as expectations.
The stock price moved down -7.2%, changed from $14.99 before the earnings release to $13.91 the day after.
The next earning report is scheduled for 02 de mar. de 2026.
Based on 5 analistas, Instil Bio, Inc. Common Stock is expected to report EPS of -$2.56 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio